Filing Details

Accession Number:
0001209191-20-064584
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-21 07:00:09
Reporting Period:
2020-12-17
Accepted Time:
2020-12-21 07:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681682 Endra Life Sciences Inc. NDRA Electromedical & Electrotherapeutic Apparatus (3845) 260579295
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744025 Bertrand Renaud Maloberti C/O Endra Life Sciences Inc.
3600 Green Court, Suite 350
Ann Arbor MI 48105
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-17 25,000 $0.73 41,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.75, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  3. Includes unvested restricted stock units.